Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL

Clinical trial NCT03567876 · COMPLETED

Trial details

NCT number: NCT03567876
Sponsor: Fondazione Italiana Linfomi - ETS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Mantle-Cell

Start date: 2018-09-03
Primary completion: 2021-07-26
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.